Quality Metrics & Ratings

CMS’s 2027 Medicare Advantage Star Ratings are driving immediate payer and investor reaction, with high-rated plan enrollment reportedly improving and issuers such as Humana and Clover seeing reputational and market upside from rating gains, while Alignment Healthcare faces pressure tied to a lower rating trajectory. For VBC stakeholders, the ratings reinforce Stars as a central revenue and growth lever in MA—shaping bonus payments, supplemental benefit capacity, contracting leverage, and quality-improvement priorities under the Trump administration’s CMS. See HFMA’s coverage of high-rated MA enrollment gains and Better Medicare Alliance’s response to the [2027 MA Star Ratings announcement](https://news.google.com